The frequency of the double risk genotype, eNOS TT and ACE DD, was found to be 4.1% in COPD group, while there was no carrier (0.0%) of such a genotype in NLF controls and VBD group, Table 4. The gene discussed is NOS3; the disease is chronic obstructive pulmonary disease.